BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like MannKind Names Lilly Exec as New CMO February 5, 2018 Acorda To Host Conference Call To Discuss Fourth Quarter 2016 On February 14, 2017 January 30, 2017 New York's Akari Puts CEO on Administrative Leave May 11, 2017
